AHX — Apiam Animal Health Share Price
Last trade - 00:00- AU$205.54m
- AU$259.43m
- AU$126.18m
- 88
- 64
- 53
- 75
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 12.66 | ||
| PEG Ratio (f) | 0.49 | ||
| EPS Growth (f) | 35.27% | ||
| Dividend Yield (f) | 3.33% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.57 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 23.6 | ||
| Price to Sales | 1.63 | ||
| EV to EBITDA | 17.96 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.13% | ||
| Return on Equity | 6.9% | ||
| Operating Margin | 6.43% | ||
Financial Summary
| Year End 30th Jun | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 97.99 | 106.6 | 111.72 | 118.33 | 126.18 | 153 | 157 | 18.46% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +137.63 | -27.75 | -15.1 | +20.02 | +7.63 | +38.6 | +33.33 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health Trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Apiam Animal Health Limited is an Australia-based animal health company, which is engaged in providing a range of products and services for production and mixed animals. The Company's services include veterinary services, ancillary services, genetics, wholesale, and retail of related products, together with technical services related to food-chain security. The Company's segments include Dairy and Mixed, Feedlots, and Pigs. Its lead program, ProDairy, is designed for dairy farmers, which promotes cow health, welfare, and production. The Company's Best Mates is a fur life vet wellness program designed to keep pets healthy and happy for life. Its swine, beef feedlot and sheep consultancy teams provide services in all aspects of production, animal husbandry, management and care, with a focus on both animal welfare and business outcomes.
Directors
- Andrew Vizard NEC
- Matthew White CFO
- Brian Scutt COO
- Christopher Richards MDR
- Eryl Baron SEC
- Michael Blommestein NID
- Richard Dennis NID
- Jan Tennent NID
- Last Annual
- June 30th, 2021
- Last Interim
- June 30th, 2021
- Incorporated
- March 25th, 2015
- Public Since
- December 15th, 2015
- No. of Shareholders
- 1,600
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 228,372,467
- Address
- East Bendigo, 27-33 Piper Lane, BENDIGO, 3550
- Web
- http://www.apiam.com.au
- Phone
- +61 354455999
- Auditors
- Grant Thornton Audit Pty Ltd
Latest News for AHX
Upcoming Events for AHX
Half Year 2022 Apiam Animal Health Ltd Earnings Release
Similar to AHX
Artrya
Australian Stock Exchange - SEATS
Artrya
Australian Stock Exchange - SEATS
Asian American Medical
Australian Stock Exchange - SEATS
Australian Clinical Labs
Australian Stock Exchange - SEATS
Cann
Australian Stock Exchange - SEATS
FAQ
As of Today at 12:03 UTC, shares in Apiam Animal Health are trading at AU$0.90. This share price information is delayed by 15 minutes.
Shares in Apiam Animal Health last closed at AU$0.90 and the price had moved by +50% over the past 365 days. In terms of relative price strength the Apiam Animal Health share price has outperformed the ASX All Ordinaries Index by +34.48% over the past year.
The overall consensus recommendation for Apiam Animal Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Apiam Animal Health dividend yield is 2.67% based on the trailing twelve month period.
Last year, Apiam Animal Health paid a total dividend of AU$0.02, and it currently has a trailing dividend yield of 2.67%. We do not have any data on when Apiam Animal Health is to next pay dividends.
We do not have data on when Apiam Animal Health is to next pay dividends. The historic dividend yield on Apiam Animal Health shares is currently 2.67%.
To buy shares in Apiam Animal Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.90, shares in Apiam Animal Health had a market capitalisation of AU$205.54m.
Here are the trading details for Apiam Animal Health:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: AHX
Based on an overall assessment of its quality, value and momentum Apiam Animal Health is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Apiam Animal Health is AU$1.29. That is 43.33% above the last closing price of AU$0.90.
Analysts covering Apiam Animal Health currently have a consensus Earnings Per Share (EPS) forecast of AU$0.06 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Apiam Animal Health. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -8.61%.
As of the last closing price of AU$0.90, shares in Apiam Animal Health were trading -2.37% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Apiam Animal Health PE ratio based on its reported earnings over the past 12 months is 12.66. The shares last closed at AU$0.90.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Apiam Animal Health's management team is headed by:
- Andrew Vizard - NEC
- Matthew White - CFO
- Brian Scutt - COO
- Christopher Richards - MDR
- Eryl Baron - SEC
- Michael Blommestein - NID
- Richard Dennis - NID
- Jan Tennent - NID